Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cerilliant
Harvard Business School
McKinsey
UBS
Fuji
Colorcon
Cipla
Chinese Patent Office

Generated: May 21, 2018

DrugPatentWatch Database Preview

MOXAM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Moxam patents expire, and when can generic versions of Moxam launch?

Moxam is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in MOXAM is moxalactam disodium. There is one drug master file entry for this compound. Additional details are available on the moxalactam disodium profile page.
Summary for MOXAM
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 34
Patent Applications: 2,398
DailyMed Link:MOXAM at DailyMed
Drug patent expirations by year for MOXAM
Medical Subject Heading (MeSH) Categories for MOXAM
Synonyms for MOXAM
(6R-(6alpha,7alpha,7(S*)))-7-((Carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[2-carboxy-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[3-hydroxy-2-(4-hydroxyphenyl)-3-oxo-propanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[3-hydroxy-2-(4-hydroxyphenyl)-3-oxopropanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[2-carboxy-2-(4-hydroxyphenyl)acetamido]-7-methoxy-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[2-Carboxy-2-(p-hydroxyphenyl)acetylamino]-7-methoxy-3-(1-methyl-1H-tetrazol-5-ylthiomethyl)-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[carboxy(4-hydroxyphenyl)acetyl]amino}-7-(methyloxy)-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[carboxy(4-hydroxyphenyl)acetyl]amino}-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
1-Oxacephalosporin
5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-
5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7alpha,7(S*)))-
5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, disodium salt
5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[carboxy(4-hydroxyphenyl)acetyl]amino]-7methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-
5-Oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-carboxy(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,(6R,7R)-
6059-S
6059S
64952-97-2
64953-12-4
649L972
7-((Carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid (6R-(6alpha,7alpha,7(S*)))-
7-[[Carboxy(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.2.o]oct-2-ene-2-carboxylic acid, disodium salt
7002AB
75007-71-5
79120-38-0
7b-[2-carboxy-2-(4-hydroxyphenyl)acetamido]-7a-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-1-oxa-1-dethia-3-cephem-4-carboxylic acid
7beta-(2-Carboxy-2-(4-hydroxyphenyl)acetamido)-7alpha-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-1-oxa-1-dethia-3-cephem-4-carboxylic acid
AC1L2I6O
AC1L9AT9
AC1Q41EH
AC1Q6LO9
AK112716
AKOS016010201
AKOS025310623
AN-38734
Antibiotic 6059-S
API0003434
BDBM50370589
BSPBio_002039
C07231
C20H20N6O9S
CAS-64953-12-4
CCG-40101
CHEBI:599928
CHEMBL1200357
CHEMBL74632
D02198
D04VXN
D08109
D0O5LU
DB04570
disodium (6R,7R)-7-[[2-(4-hydroxyphenyl)-3-oxido-3-oxopropanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
disodium (6R,7R)-7-[2-carboxylato-2-(4-hydroxyphenyl)acetamido]-7-methoxy-3-{[(1-methyl-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Disodium 7-((carboxylato(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
Disodium latamoxef
Disodium Moxalactam
DivK1c_000909
DR003144
DSSTox_CID_25595
DSSTox_GSID_45595
DSSTox_RID_80988
DTXSID0045595
DTXSID9023338
EINECS 265-287-9
EINECS 265-288-4
Epitope ID:180870
Festamoxin
FT-0774374
HE373898
HMS1570D19
HMS1920P05
HMS2091H04
HMS502N11
IDI1_000909
KB-292847
KBio1_000909
KBio2_001451
KBio2_004019
KBio2_006587
KBio3_001539
KBioGR_000587
KBioSS_001451
Lamoxactam
Latamoxef
Latamoxef (INN)
Latamoxef [INN:BAN]
latamoxef disodium
latamoxef sodium
Latamoxef sodium (JP17)
Latamoxefum
Latamoxefum [INN-Latin]
Lilly 127935
Listeria mox supplement
LMOX
LS-98586
LY 127935
LY-127935
Ly127935
MFCD03427565
moxalactam
MOXALACTAM DISODIUM
Moxalactam disodium (USAN)
Moxalactam disodium [USAN:USP]
Moxalactam disodium salt
Moxalactam Sodium
Moxalactam Supplement, for microbiology
Moxam (TN)
N-((6R,7R)-2-Carboxy-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo(4.2.0)oct-2-en-7-yl)-2-(p-hydroxyphenyl)malonamic acid disodium salt
NCGC00017130-01
NCGC00178851-03
NINDS_000909
Oxa-cephem
Prestwick_33
Prestwick0_000819
Prestwick1_000819
Prestwick2_000819
S-6059
SBI-0051450.P003
SC-50884
SCHEMBL194012
SCHEMBL49015
Shiomarin
Shiomarin (TN)
Shionogi 6059S
Sid 734787
SMP1_000200
SPBio_001054
SPBio_002638
Spectrum_000971
SPECTRUM1500418
Spectrum2_001067
Spectrum3_000510
Spectrum4_000064
Spectrum5_001371
Tox21_110793
Tox21_110793_1

US Patents and Regulatory Information for MOXAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly MOXAM moxalactam disodium INJECTABLE;INJECTION 050550-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly MOXAM moxalactam disodium INJECTABLE;INJECTION 050550-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly MOXAM moxalactam disodium INJECTABLE;INJECTION 050550-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly MOXAM moxalactam disodium INJECTABLE;INJECTION 050550-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
QuintilesIMS
Farmers Insurance
Teva
Fish and Richardson
Deloitte
Federal Trade Commission
UBS
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.